Kolon Tissue Gene, Inc. reported raising $30.1 Million in an initial SEC Form D filing, from an offering of $30.1 Million
Amount Raised
$30.1 Million
Round Type
Venture
Quick answer
Kolon TissueGene, Inc. raised $30.1 Million in a funding round, dated December 16, 2021. Kolon TissueGene, Inc. is based in Rockville, Maryland, United States.
- How much did Kolon TissueGene, Inc. raise?
- Kolon TissueGene, Inc. raised $30.1 Million in a funding round on December 16, 2021.
- What does Kolon TissueGene, Inc. do?
- At Kolon TissueGene, our mission is to provide safe and effective therapies to patients by reducing pain and improving function associated with various orthopedic diseases and degenerative disorders.
- Where is Kolon TissueGene, Inc. based and how big is it?
- Kolon TissueGene, Inc. is based in Rockville, Maryland, United States.
- Who are the decision-makers at Kolon TissueGene, Inc?
- Fundz holds 1 contact at Kolon TissueGene, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Kolon TissueGene, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Kula Bio raised $50M on January 28, 2022.
- Crossfire Medical Inc raised $3M (Seed) on January 27, 2022.
- Kula Bio raised $50M (Series A) on January 27, 2022.
- Septerna raised $100M (Series A) on January 27, 2022.
- NextRNA Therapeutics raised $23M on January 27, 2022.
- Metagenomi Therapeutics, Inc. raised $175M (Series B) on January 26, 2022.
Who to call at Kolon TissueGene, Inc., and when
A new round usually means Kolon TissueGene, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kolon TissueGene, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kolon TissueGene, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kolon TissueGene, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kolon TissueGene, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kolon TissueGene, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.